BILL Filing Discloses 3,971-Share Sale; Prior 10b5-1 Sales Total 4,261 Shares

Rhea-AI Filing Summary

Form 144 notice for BILL Holdings, Inc. (symbol provided in metadata) documents a proposed sale of 3,971 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $184,333.82, with an approximate sale date listed as 09/02/2025 on the NYSE. The filing lists recent sales over the past three months under 10b5-1 plans: 1,780 shares on 06/24/2025 (gross proceeds $80,545.00) and 2,481 shares on 06/03/2025 (gross proceeds $111,645.00).

The acquisition rows show the securities to be sold were recorded as received from the issuer as Performance Stock Units (507) and Restricted Stock Units (3,464) on 08/28/2025. The filing includes the standard Rule 144 attestation and a signature block; several issuer/filer identification fields in the form appear blank in the provided content.

Positive

• Proposed sale fully disclosed with broker (Morgan Stanley Smith Barney LLC), exchange (NYSE), share count (3,971) and aggregate market value ($184,333.82).
• Past 10b5-1 plan sales disclosed with dates and gross proceeds: 1,780 shares on 06/24/2025 ($80,545.00) and 2,481 shares on 06/03/2025 ($111,645.00).
• Source of shares documented as Performance Stock Units (507) and Restricted Stock Units (3,464) with acquisition dates noted.

Negative

• Issuer/filer identification fields are missing in the supplied content (e.g., issuer name and filer CIK not provided), limiting external verification.
• Acquisition and sale dates are presented without context (e.g., 08/28/2025 acquisitions and 09/02/2025 proposed sale), and the filing alone does not clarify total insider holdings or intent.
• Materiality to investors unclear because the filing does not state the filer’s total ownership stake or the company market capitalization for context.

Insights

Financial Analyst

TL;DR: Insider-related sales disclosed totaling 3,971 shares planned and 4,261 shares sold recently; proceeds are modest relative to large-cap issuers.

The filing reveals a proposed disposition of 3,971 common shares valued at $184,333.82 to be executed via Morgan Stanley on the NYSE. Historical 10b5-1 plan sales over June 2025 total 4,261 shares for $192,190.00 in gross proceeds. These amounts are material for an individual insider but may be immaterial to company-wide capitalization given the listed shares outstanding of 101,628,611. The record also notes recent equity awards (507 PSUs and 3,464 RSUs) acquired from the issuer on 08/28/2025, which may explain the source of saleable securities. Overall impact on valuation appears neutral absent additional context on total insider holdings or company market cap.

Compliance Specialist

TL;DR: The filing follows Rule 144 and discloses 10b5-1 plan sales, but key issuer/filer identification fields are missing in the provided text.

The document provides required disclosure of the proposed sale, broker, exchange, share counts, and past sales under 10b5-1 plans, supporting procedural compliance. However, several form fields that typically identify the filer and issuer (CIK, issuer name, address, submission contact) are blank in the supplied content, which limits verification. The form includes the standard Rule 144 representation and statements about reliance on a 10b5-1 plan where applicable.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3971	184333.82	101628611	09/02/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/28/2025	Performance Stock Units	Issuer			507	08/28/2025	N/A
Common	08/28/2025	Restricted Stock Units	Issuer			3464	08/28/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales Plan for RAJESH AJI 6220 America Center Dr., Suite 100 San Jose CA 95002	Common	06/24/2025	1780	80545.00
10b5-1 Sales Plan for RAJESH AJI 6220 America Center Dr., Suite 100 San Jose CA 95002	COMMON	06/03/2025	2481	111645.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the Form 144 for BILL propose to sell?

The notice lists a proposed sale of 3,971 common shares through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $184,333.82.

Were there any recent 10b5-1 sales disclosed for BILL insiders?

Yes. The filing discloses two 10b5-1 plan sales: 1,780 shares on 06/24/2025 for $80,545.00 and 2,481 shares on 06/03/2025 for $111,645.00.

What is the source of the securities being sold according to the filing?

The securities to be sold are shown as acquired from the issuer as Performance Stock Units (507) and Restricted Stock Units (3,464) with acquisition dates of 08/28/2025.

Does the filing include the filer or issuer CIK and contact information?

In the provided content, key filer and issuer identification fields (such as the CIK and issuer name/address) are not provided or appear blank.

What representation does the person selling make in the Form 144?

The filer attests they do not know any material nonpublic information about the issuer and includes the standard Rule 144 and 10b5-1 plan representation language and signature block.